The COVID-19 pandemic and in fact all crises – acute or prolonged – remind us that human rights need to be central in all recovery and development efforts. The Sustainable Development Goals will only be achieved if we are able to create equal opportunities for all, address failures exposed and e...xploited by COVID-19, and apply human rights standards to tackle entrenched, systematic, and intergenerational inequalities, exclusion and discrimination.
We also share examples from Dorcas’ practice and formulate recommendations based on good practices of other organisations as well as our own. With this report, we aim to inform and inspire policy makers and humanitarian and development practitioners on inclusion of the rights of Older People in the current COVID-19 crisis, as well as others yet to come.
more
Verlässliche Antworten und konkrete Informationen, wie Sie sich schützen und anderen helfen können
Aufklärungsplattform des Bundeministerium für Gesundheit
Epidemiologisches Bulletin3 | 202121. Januar 2021 (online vorab)
Verhaltenstipps, Arbeitsrecht und Reisebestimmungen auf einen Blick. Die Informationen werden laufend erweitert und aktualisiert und sind in folgenden Sprachen verfügbar
| English/Englisch | Türkçe/Türkisch | Polski/Polnisch | Français/Französisch | Italiano/Italienisch |
| ελληνικ...ά/Griechisch | Hrvatski/Kroatisch | Română/Rumänisch | Български/Bulgarisch | | Magyar/Ungarisch | دری /Dari - فارسی /Farsi | 中文语言/Chinesisch | Español / Spanisch | | عربي/Arabisch | Tiếng Việt/Vietnamesisch | Shqip / Albanisch | Русский / Russisch | | ትግርኛ / Tigrinja | Česky / Tschechisch |
more
PhD Martin Moder, österreichischer Molekularbiologe, Autor populärwissenschaftlicher Bücher und Teil der Wissenschaftskabarettgruppe Science Busters, erklärt die Wirkweise und potentiellen Risiken der mRNA-Impfstoffe gegen COVID19
Version 3 Dec. 2020
The COVID-19 Vaccine Introduction Readiness Assessment Tool (VIRAT)2, developed by WHO in collaboration with PAHO is a tool for the national authorities, that allows for the establishment of a roadmap and to monitor progress in the preparation of the activities related to the in...troduction of the COVID-19 vaccines.
more
16 Dec. 2020
This document provides guidance to Ministries of Health (MOHs), laboratory personnel and implementing partners in African Union Member States on the application of rapid antigen tests to COVID-19 testing. The guidance serves as reference for policymakers, laboratory leads, implementing... partners, and experts on use case scenarios and associated testing algorithms for COVID-19 antigen tests. It recommends the use of antigen tests to increase access to testing and enable timely results for persons with or without symptoms in specific settings. The document will be reviewed and updated as more evidence becomes available regarding the use of rapid antigen tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from global studies and evaluation efforts.
more
When can we expect a vaccine for COVID-19? How will we ensure that it is safe? Who should be vaccinated first and why? Find out the answers to these and other questions.
How do vaccines work to protect us? What are the vaccine technologies in the pipeline and how do we ensure safe vaccines? Dr Katherine O’ Brien explains in Science in 5 !
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
В этом документе представлены временные рекомендации для лабораторий и других заинтересованных сторон,
принимающих участие в диагностической работе для выявлен...ия коронавируса тяжелого острого респираторного
синдрома – 2 (SARS-CoV-2). В нем освещены основные соображения касательно взятия биологических образцов,
применения методов амплификации нуклеиновых кислот (МАНК), определения антигенов (Аг) и антител (Ат), а также
обеспечения качества.
more
Рекомендации для населения в отношении инфекции, вызванной новым коронавирусом (COVID-19)